Medtronic Plc [NYSE: MDT] stock went on an upward path that rose over 10724919% on Tuesday, amounting to a one-week price decrease of less than -2.09%.
Over the last 12 months, MDT stock rose by 7.76%. The one-year Medtronic Plc stock forecast points to a potential downside of -8202528.23. The average equity rating for MDT stock is currently 2.24, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $110.29 billion, with 1.28 billion shares outstanding and 1.28 billion shares in the current float. Compared to the average trading volume of 7.74M shares, MDT stock reached a trading volume of 10724919 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Medtronic Plc [MDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $94.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 2.24. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Medtronic Plc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 16, 2025. While these analysts kept the previous recommendation, Citigroup dropped their target price from $92 to $107. The new note on the price target was released on March 04, 2025, representing the official price target for Medtronic Plc stock. Previously, the target price had yet another raise from $98 to $105, while RBC Capital Mkts kept a Outperform rating on MDT stock. On August 21, 2024, analysts increased their price target for MDT shares from 92 to 94.
The Price to Book ratio for the last quarter was 2.30, with the Price to Cash per share for the same quarter was set at 7.00. Price to Free Cash Flow for MDT in the course of the last twelve months was 21.27 with Quick ratio for the last quarter at 1.42.
MDT Stock Performance Analysis:
Medtronic Plc [MDT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.09. With this latest performance, MDT shares gained by 6.39% in over the last four-week period, additionally plugging by 7.56% over the last 6 months – not to mention a rise of 7.76% in the past year of trading.
Insight into Medtronic Plc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Medtronic Plc [MDT] shares currently have an operating margin of 18.68% and a Gross Margin at 59.79%. Medtronic Plc’s Net Margin is presently recorded at 13.90%.
Return on Equity for this stock inclined to 5.13%, with Return on Assets sitting at 5.13%.
MDT Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic Plc go to 5.54%.
Medtronic Plc [MDT] Institutonal Ownership Details
There are presently around $87.08%, or 87.31% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 126.61 million shares, which is approximately 9.7895%. BLACKROCK INC., holding 111.89 million shares of the stock with an approximate value of $$8.81 billion in MDT stocks shares; and BLACKROCK INC., currently with $$4.78 billion in MDT stock with ownership which is approximately 4.6556%.
